Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery | Oncotarget

HER2-Low Breast Cancer: Genomic Insights and Evolving Treatment Paradigms | Oncotarget

Anti-Correlation Between KLRG1 and PD-1 in Tumor CD8 T Cells | Oncotarget

Pitfalls of FDA-Approved Germline Cancer Predisposition Tests | Oncotarget

Breakthroughs in Cell-Penetrating Monoclonal Antibody Therapies | Oncotarget

CT Radiomics and Body Composition for Predicting Hepatic Decompensation | Oncotarget

B7-H4 as a Therapeutic Target in Adenoid Cystic Carcinoma | Oncotarget

Mesenchymal Stem Cells in Cancer Immunotherapy: Promises and Challenges | Oncotarget

Persistence Landscapes: A Path to Unbiased Radiological Interpretation | Oncotarget

Visualizing Radiological Data Bias with Persistence Images | Oncotarget

Persistence Barcodes: Reducing Bias in Radiological Analysis | Oncotarget

Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC | Oncotarget

Reducing Bias in Radiology with Topological Data Analysis | Oncotarget

Extracellular Matrix and Tumor-Immune Interactions: Challenges & Opportunities | Oncotarget

Navigating Bias in AI-Driven Cancer Detection | Oncotarget

Precision Medicine in SCLC: DLL3, ASC1, TTF-1, and Ki-67 Expression | Oncotarget

Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer | Oncotarget

Tumor Dormancy Initiated by Lymphovascular Embolus | Oncotarget

Complete Response to Encorafenib + Binimetinib in BRAF V600E-Mutant Tumor | Oncotarget

Behind the Study: Molecular Chaperones & Tumor Suppressor Stability | Oncotarget

How Blood Cancer Cells Rewire to Evade Drug Treatment | Oncotarget

Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget

Molecular Chaperones: Guardians of Tumor Suppressor Stability | Oncotarget

TP53 Mutated AML: Transplant or No Transplant | Oncotarget

Zika Virus as a Treatment for Brain Cancer: A Systematic Review | Oncotarget

Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy | Oncotarget

UBA1 Dysfunction in VEXAS and Cancer | Oncotarget

FOXM1 and PD-L1 in CDK4/6-MEK Resistance in Nerve Tumors | Oncotarget

AI's Role in Advancing Intratumoral Immunotherapy | Oncotarget

ISR Activation & Apoptosis via HRI Kinase by PG3 and Other p53 Cancer Therapies | Oncotarget

Targeting CD47/SIRPα 'Do Not Eat Me' Axis: Advances and Challenges in Cancer Therapy | Oncotarget

Next-Gen Vaccines Offer New Hope Against Glioblastoma | Oncotarget

Generative AI in Cancer Imaging: Revolutionizing Detection & Diagnosis | Oncotarget

Case for Inflammatory Memory for Hematopoietic Stem and Progenitor Cells in AML Niche | Oncotarget

Targeting WNT5B and WNT10B in Osteosarcoma | Oncotarget

Graph Filtration Learning Reveals New Dimensions in Hepatocellular Carcinoma Imaging | Oncotarget

miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer | Oncotarget

Artificial Intelligence: Revolutionizing Precision Oncology | Oncotarget

Genotype Matters: Tailored Screening for Germline CHEK2 Variants | Oncotarget

Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity | Oncotarget

Gut Barrier as Gatekeeper in Colorectal Cancer Treatment | Oncotarget

Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice | Oncotarget

Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors | Oncotarget

New Directions in Targeting the Multifaceted BRAF in Cancer | Oncotarget

CDR3s and Renalase-1 Correlate with Increased Melanoma Survival | Oncotarget

How to Deal with Runaway Metastatic Disease? | Oncotarget

INT-1B3 miR-193a-3p Mimic Boosts T Cell Anti-Tumor Response | Oncotarget

Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis | Oncotarget

Prognostic and Therapeutic Insights into MIF, DDT, and CD74 in Melanoma | Oncotarget

Enhanced Pembrolizumab Efficacy with EphB4-Albumin in HPV-Negative Head and Neck Cancer | Oncotarget

DDX41 and its Unique Contribution to Myeloid Leukemogenesis | Oncotarget

Early ctDNA as Response Assessment in Metastatic Prostate Cancer | Oncotarget

HER2-Low and HER2-Zero in Breast Cancer: Prognosis & Prediction | Oncotarget

FDG-PET/CT vs. CT for Tumor Response to Nivolumab Plus Ipilimumab in Mesothelioma | Oncotarget

Targeting ABC Transporters in PDAC – Past, Present or Future? | Oncotarget

Regorafenib and TAS102 Synergize Against Gastrointestinal Cancers | Oncotarget

Genomics Has More to Reveal | Oncotarget

Enhancing DNA Damage and Immunotherapy by Starving Cancer Cells | Oncotarget

Leveraging Gold Nanostars for Precision Laser Interstitial Thermal Therapy | Oncotarget

Serum Tumor Markers in NSCLC Management | Oncotarget